Cargando…

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

BACKGROUND AND AIMS: Variant in glucokinase regulatory protein (GCKR), associated with lipid and glucose traits, has been suggested to affect fatty liver infiltration. We aimed to assess whether GCKR rs780094 C→T SNP influences the expression of steatosis, lobular inflammation and fibrosis in NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petta, Salvatore, Miele, Luca, Bugianesi, Elisabetta, Cammà, Calogero, Rosso, Chiara, Boccia, Stefania, Cabibi, Daniela, Di Marco, Vito, Grimaudo, Stefania, Grieco, Antonio, Pipitone, Rosaria Maria, Marchesini, Giulio, Craxì, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911959/ https://www.ncbi.nlm.nih.gov/pubmed/24498332 http://dx.doi.org/10.1371/journal.pone.0087523

Ejemplares similares

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2013)

Serum γ-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases
por: Petta, Salvatore, et al.
Publicado: (2012)

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease
por: Pennisi, Grazia, et al.
Publicado: (2022)

Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development
por: Pipitone, Rosaria Maria, et al.
Publicado: (2022)

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
por: Turola, Elena, et al.
Publicado: (2015)

Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
por: Pastore, Mirella, et al.
Publicado: (2019)

The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2015)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
por: Donati, Benedetta, et al.
Publicado: (2017)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study
por: Amodio, Emanuele, et al.
Publicado: (2020)

PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19
por: Grimaudo, Stefania, et al.
Publicado: (2021)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
por: Pennisi, Grazia, et al.
Publicado: (2023)

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort
por: Almasio, Piero Luigi, et al.
Publicado: (2016)

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
por: Calvaruso, Vincenza, et al.
Publicado: (2021)

Insulin-Receptor Substrate-2 (IRS-2) Is Required for Maintaining Glucokinase and Glucokinase Regulatory Protein Expression in Mouse Liver
por: Roncero, Isabel, et al.
Publicado: (2013)

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity
por: Di Mauro, Stefania, et al.
Publicado: (2019)

Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
por: Foglia, Beatrice, et al.
Publicado: (2019)

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
por: Donati, Benedetta, et al.
Publicado: (2017)

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease
por: Bayoumi, Ali, et al.
Publicado: (2020)

Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis
por: Cabibi, Daniela, et al.
Publicado: (2015)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

Evolution of Hepatic Glucose Metabolism: Liver-Specific Glucokinase Deficiency Explained by Parallel Loss of the Gene for Glucokinase Regulatory Protein (GCKR)
por: Wang, Zhao Yang, et al.
Publicado: (2013)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Gallstone Disease Is Associated with More Severe Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2012)

Role of Glucokinase in the Subcellular Localization of Glucokinase Regulatory Protein
por: Jin, Ling, et al.
Publicado: (2015)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients
por: Brodosi, Lucia, et al.
Publicado: (2021)

Correction: Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
Publicado: (2014)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
por: Fianchi, Francesca, et al.
Publicado: (2021)

Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease
por: Gaggini, Melania, et al.
Publicado: (2019)

Association of rs780094 polymorphism of glucokinase regulatory protein with non-alcoholic fatty liver disease
por: Mohammadi, Saba, et al.
Publicado: (2020)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dldksahgp805s1hrp7rc6fvhi4